What is Interpharm Holdings, Inc. (IPAH) stock price today?

Interpharm Holdings, Inc. (IPAH) is currently trading at $0.00.

What is IPAH return on equity (ROE)?

Interpharm Holdings, Inc.'s return on equity (ROE) is -117.07%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Interpharm Holdings, Inc.'s market cap?

Interpharm Holdings, Inc. has a market capitalization of $660.

OTC · Medical - Pharmaceuticals

Interpharm Holdings, Inc. (IPAH) Stock

$0.00 OTC: IPAH Healthcare

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties.

Valuation

Metric	Value
Price	$0.00
Market Cap	$660
P/E Ratio	—
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-117.07%
ROA	-18.53%
ROCE	-25.58%
Gross Margin	17.34%
Operating Margin	-24.28%
Net Margin	-42.42%
Debt/Equity	3.43
Current Ratio	0.62

Annual Financials (USD)

Metric	2002	2003	2004	2005	2006
Revenue	—	$41.0M	$40.0M	$63.0M	$76.0M
Operating Profit	—	$5.0M	$0	$-5.0M	$-11.0M
Net Profit	—	$3.0M	$0	$-4.0M	$-14.0M
EPS	—	$0.04	$-0.01	$-0.15	$-0.26
Op Margin	—	12.3%	-0.2%	-7.5%	-14.2%

Balance Sheet (USD)

Metric	2002	2003	2004	2005	2006
Total Assets	$20.0M	$35.0M	$46.0M	$63.0M	$74.0M
Total Liabilities	$8.0M	$12.0M	$23.0M	$40.0M	$63.0M
Cash	$2.0M	$3.0M	$1.0M	$1.0M	$0
Borrowings	$3.0M	$8.0M	$17.0M	$16.0M	$27.0M

Cash Flow (USD)

Metric	2002	2003	2004	2005	2006
Operating Cash Flow	—	$2.0M	$-2.0M	$1.0M	$-14.0M
Investing Cash Flow	—	$-7.0M	$-18.0M	$-15.0M	$-16.0M
Financing Cash Flow	—	$0	$0	$0	$0
Net Cash Flow	—	$1.0M	$-2.0M	$1.0M	$-1.0M
Free Cash Flow	$0	$-2.0M	$-10.0M	$-6.0M	$-22.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	3.16
EV / EBITDA	-3.32
FCF Yield	-3333333.33%
Quick Ratio	0.31
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CBGLCannabis Global Inc.	$0.00	—	-3.40	$56821	0.00%
DNAGDNAPrint Genomics, Inc.	$0.00	—	—	$12892	0.00%
IMMBImmunotech Laboratories, Inc.	$0.00	—	-0.22	$114993	0.00%
INLBItem 9 Labs Corp.	$0.00	—	0.00	$70181	0.00%
JNHMFJack Nathan Medical Corp.	$0.00	—	-0.70	$87099	0.00%

About Interpharm Holdings, Inc.

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.

Interpharm Holdings, Inc. (IPAH) stock trades at $0.00 with a market capitalization of $660. The stock is valued at price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Interpharm Holdings, Inc. generates a return on equity (ROE) of -117.07%, return on capital employed of -25.58%, an operating margin of -24.28%, a net profit margin of -42.42%.

Official website: www.interpharmusa.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides